Result of AGM

RNS Number : 2555L

Genedrive PLC

29 December 2022

 

genedrive plc

("genedrive" or the "Company")

Result of AGM

genedrive plc (LSE: GDR), the near patient molecular diagnostics company, announces that at the Annual General Meeting, held today, all resolutions proposed were duly passed.

For information, details of the proxy voting are shown below:

Resolutions	Votes For	Vote For (as % of votes cast)	Votes Against	Votes Against (as % of votes cast)	Vote Withheld
1	9,314,654	95.9%	396,009	4.1%	749,665
2	8,398,949	82.0%	1,847,623	18.0%	213,756
3	7,804,248	79.2%	2,045,968	20.8%	610,112
4	7,804,248	79.9%	1,958,332	20.1%	697,748
5	6,887,924	68.5%	3,165,195	31.5%	407,209
6	6,474,868	74.7%	2,193,549	25.3%	1,791,911
7	8,676,922	88.1%	1,173,294	11.9%	610,112
8	8,646,108	93.4%	608,071	6.6%	1,206,149
9	8,031,215	84.1%	1,515,314	15.9%	913,799
10	7,205,751	75.3%	2,357,879	24.7%	896,698

The full text of each of the resolutions is set out in the notice of Annual General Meeting, copies of which are available on the Company's website ( www.genedriveplc.com ).

Although all the resolutions were passed, the Board of genedrive notes that more than 20% of votes were cast against the reappointment of certain directors and the resolution to generally disapply pre-emption rights (subject to certain limits).  While the Board believes that all these directors bring considerable experience and expertise to the Board, it intends to engage with shareholders to better understand their concerns on the resolutions.

For further details please contact:

genedrive plc	[phone]
David Budd: CEO / Russ Shaw: CFO
Peel Hunt LLP (Nominated Adviser and Joint Broker)	[phone]
James Steel / Oliver Duckworth
finnCap (Joint Broker)	[phone]
Geoff Nash / George Dollemore / Nigel Birks / Alice Lane
Walbrook PR Ltd (Media Relations & IR)	[phone] or [e-mail]
Paul McManus / Anna Dunphy	[phone]

 

END

 

 

RAGBIBDDLGDDGDC